Panacea Biotec shares up nearly 5% on vaccine launch

Shares of Panacea Biotec today advanced by nearly 5 per cent after the company announced launch of EasySix, a liquid hexavalent combination vaccine indicated for immunisation of newborn babies against common preventable diseases.
The scrip gained 4.68 per cent to end at Rs 161.15 on BSE. During the day, it rose sharply by 8.99 per cent to Rs 167.80.
On NSE, shares of the company jumped 4.21 per cent to close at Rs 161.90.
This is world's first fully liquid whole cell pertussis based vaccine and would work against diseases such as diphtheria, tetanus, whooping cough, meningitis, hepatitis B and polio, Panacea Biotec said in a statement.

Pancea Biotec has been developing superior innovative vaccines against infective diseases for more than three decades.